Analysis of the structural and mechanical effects of procoagulant agents on neonatal fibrin networks following cardiopulmonary bypass

Ignjatovic, 2011, Age‐related differences in plasma proteins: how plasma proteins change from neonates to adults, PLoS ONE, 6, e17213, 10.1371/journal.pone.0017213 Ignjatovic, 2011, The coagulation system in children: developmental and pathophysiological considerations, Semin Thromb Hemost, 37, 723, 10.1055/s-0031-1297162 Revel‐Vilk, 2012, The conundrum of neonatal coagulopathy, Hematology Am Soc Hematol Educ Program, 2012, 450, 10.1182/asheducation.V2012.1.450.3798660 Brown, 2016, Fibrin network changes in neonates after cardiopulmonary bypass, Anesthesiology, 124, 1021, 10.1097/ALN.0000000000001058 Guzzetta, 2015, Excessive postoperative bleeding and outcomes in neonates undergoing cardiopulmonary bypass, Anesth Analg, 120, 405, 10.1213/ANE.0000000000000531 Wolf, 2014, Early postoperative bleeding is independently associated with increased surgical mortality in infants after cardiopulmonary bypass, J Thorac Cardiovasc Surg, 148, 631, 10.1016/j.jtcvs.2013.10.050 Manlhiot, 2011, Risk, clinical features, and outcomes of thrombosis associated with pediatric cardiac surgery, Circulation, 124, 1511, 10.1161/CIRCULATIONAHA.110.006304 Undas, 2014, Fibrin clot properties and their modulation in thrombotic disorders, Thromb Haemost, 112, 32, 10.1160/TH14-01-0032 Undas, 2011, Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases, Arterioscler Thromb Vasc Biol, 31, e88, 10.1161/ATVBAHA.111.230631 Awad, 2013, Activated prothrombin complex concentrates for the reversal of anticoagulant‐associated coagulopathy, Pharm Ther, 38, 696 Jeremy H. PCC Dosing Information. [online] University of Missouri‐Kansas City School Of Medicine. Available at: http://med.umkc.edu/docs/em/PCC_dosing_information.pdf. Kcentra.com. Dosage Calculator Kcentra® (Prothrombin complex concentrate [human]). 2018 [online] Available at: https://www.kcentra.com/dosagecalculator?gclid=Cj0KCQjwz93cBRCrARIsAEFbWsiW19KTEnHjyfluPCaSpgIj57y-ExLgQTxmNnk2zxRucDkK07q0FFsaAlNQEALw_wcB. Prescriber's Digital Referennce Coagulation factor VIIa recombinant‐ Drug Summary. 2018 [online] Available at: http://www.pdr.net/drug-summary/NovoSeven-RT-coagulation-factor-VIIa--recombinant--458 Sproul E, Nandi S, Brown AC. Methods in Molecular Biology‐Biomaterials. New York, NY: Springer, in press. Brown, 2015, Molecular interference of fibrin's divalent polymerization mechanism enables modulation of multiscale material properties, Biomaterials, 49, 27, 10.1016/j.biomaterials.2015.01.010 Timmins, 2010, Structural inhomogeneity and fiber orientation in the inner arterial media, Am J Physiol Heart Circ Physiol, 298, H1537, 10.1152/ajpheart.00891.2009 Franklin, 2016, Optimizing thrombin generation with 4‐factor prothrombin complex concentrates in neonatal plasma after cardiopulmonary bypass, Anesth Analg, 122, 935, 10.1213/ANE.0000000000001098 Allen, 2004, Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system, J Thromb Haemost, 2, 402, 10.1111/j.1538-7933.2003.00617.x Zeng, 2017, Effectiveness of prothrombin complex concentrate (PCC) in neonates and infants with bleeding or risk of bleeding: a systematic review and meta‐analysis, Eur J Pediatr, 176, 581, 10.1007/s00431-017-2877-0 Mitsiakos, 2007, Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases, J Pediatr Hematol Oncol, 29, 145, 10.1097/MPH.0b013e3180335bcb Tran, 2013, Biomechanics of haemostasis and thrombosis in health and disease: from the macro‐ to molecular scale, J Cell Mol Med, 17, 579, 10.1111/jcmm.12041 Weisel, 2010, Biomechanics in hemostasis and thrombosis, J Thromb Haemost, 8, 1027, 10.1111/j.1538-7836.2010.03808.x Weisel, 2008, The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate, Cardiovasc Hematol Agents Med Chem, 6, 161, 10.2174/187152508784871963 Longstaff, 2011, The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies, Blood, 117, 661, 10.1182/blood-2010-06-290338 Undas, 2017, Prothrombotic fibrin clot phenotype in patients with deep vein thrombosis and pulmonary embolism: a new risk factor for recurrence, Biomed Res Int, 2017, 8196256, 10.1155/2017/8196256 Collet, 1996, Fibrinogen Dusart: electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots, Biophys J, 70, 500, 10.1016/S0006-3495(96)79596-6 Faraoni, 2017, Relationship between transfusion of blood products and the incidence of thrombotic complications in neonates and infants undergoing cardiac surgery, J Cardiothorac Vasc Anesth, 6, 1943, 10.1053/j.jvca.2017.04.039